GSK Investigational Site

West Yarmouth, Massachusetts 02673

0 studies enrolling now · 8 studies all time

What they study most

Alzheimer's Disease, Crohn's Disease, Diabetes Mellitus, Type 2, Dyskinesias, Hypertension, Neoplasms, Prostate, Parkinson Disease, Parkinson's Disease, Restless Legs Syndrome, Restless Legs Syndrome (RLS)

Studies at this site

• COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension — Completed
• Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Study In People With Type 2 Diabetes — Completed
• Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's — Completed
• RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease — Completed